DELIVERED TO GOVERNOR
Email me when S 8925 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 8925. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill adds a new section to the New York General Business Law that makes it illegal for any business operating in the state to sell, offer, or deliver products containing 7‑hydroxymitragynine above a small threshold. Violations are subject to civil fines of up to $500 for a first offense and $1,000 for each subsequent offense, payable to the state. The measure is intended to limit the availability of this potent opioid derivative.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 8925
3 free questions a day, no accountHistory
- RETURNED TO SENATE
- PASSED ASSEMBLY
- SUBSTITUTED FOR A9156B
- ORDERED TO THIRD READING RULES CAL.408
- REFERRED TO WAYS AND MEANS
- PASSED SENATE
- DELIVERED TO ASSEMBLY
- ADVANCED TO THIRD READING
- 2ND REPORT CAL.
- 1ST REPORT CAL.1297
- PRINT NUMBER 8925A
- AMEND AND RECOMMIT TO CONSUMER PROTECTION
The 12 most recent of 13 recorded actions.
Sponsors
- Christopher Ryan (D) · sponsor
- Anthony H. Palumbo
- Dean Murray
- Jake Ashby
- Patricia Fahy
- Pete Harckham
- Steve Rhoads
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 8925 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 8925 freeOr ask your AI assistant about S 8925 directly:
Add to Claude, ChatGPT or Cursor